Hard to believe?, page-58

In her last interview in January LC mentioned to meet with FDA next months, which would be February. The shutdown in the US had affected the FDA as well, maybe there is a 4 week delay, hard to tell.

We only get told what they think is worth to be reported or must be reported according to ASX rules, we have to trust them whether we like it or not. Phase 2 recruiting / dosing should be starting soon, but the criteria are harder than outlined on the trial website as there are very tight conditions on the cancer type. I had asked her about the criteria to participate in the trial and she came up with a huge list of requirements just for blood properties / specifications. Only a fraction of applicants are eligible, that's one reason for some delays. They really go by the rules so nobody can question the results. They make it bulletproof, but it takes its time.

Last year someone told me that LC is renown for her trial ethics, no short cuts at all, 100% compliance, solid results. I think we owe IMU the time they need.

GLTA